HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liesbeth M Kager Selected Research

Liesbeth M Kager Research Topics

Disease

10Melioidosis
01/2015 - 02/2010
10Sepsis (Septicemia)
11/2014 - 02/2010
8Infections
01/2015 - 02/2012
7Inflammation (Inflammations)
01/2015 - 03/2010
5Tuberculosis (Tuberculoses)
10/2017 - 08/2012
4Pneumonia (Pneumonitis)
05/2014 - 03/2010
2Pulmonary Tuberculosis
10/2017 - 12/2015
2Pneumococcal Pneumonia
11/2014 - 05/2014
1Pain (Aches)
01/2021
1Neuralgia (Stump Neuralgia)
01/2021
1Pancreatitis
01/2020
1Typhoid Fever (Typhoid)
01/2018
1Asthma (Bronchial Asthma)
12/2015
1Osteomyelitis
05/2014
1Tuberculoma
05/2014
1Cholecystitis
02/2012
1Cholangitis
02/2012
1Multiple Myeloma
01/2009

Drug/Important Bio-Agent (IBA)

6Protein CIBA
12/2015 - 04/2013
5CytokinesIBA
05/2014 - 08/2012
3AnticoagulantsIBA
01/2018 - 11/2014
3Proteins (Proteins, Gene)FDA Link
12/2015 - 03/2010
3Endothelial Protein C ReceptorIBA
05/2014 - 01/2013
3ThrombomodulinIBA
04/2014 - 02/2014
2LectinsIBA
03/2014 - 02/2014
1Opioid Analgesics (Opioids)IBA
01/2021
1Triglycerides (Triacylglycerol)IBA
01/2020
1CalciumIBA
01/2020
1Alanine Transaminase (SGPT)IBA
01/2020
1Nucleosomes (Nucleosome)IBA
10/2017
1Leukocyte Elastase (Neutrophil Elastase)IBA
10/2017
1Pancreatic Elastase (Elastase)IBA
10/2017
1Triggering Receptor Expressed on Myeloid Cells-1IBA
12/2015
1drotrecogin alfa activated (Xigris)FDA Link
12/2015
1Granzymes (Granzyme)IBA
09/2015
1LipopolysaccharidesIBA
01/2015
1Biological Warfare AgentsIBA
01/2015
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2015
1Pharmaceutical PreparationsIBA
11/2014
1ParaffinIBA
05/2014
1AcidsIBA
05/2014
1Peptide Hydrolases (Proteases)FDA Link
02/2014
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2013
1Glyburide (Glibenclamide)FDA LinkGeneric
01/2013
1Tuberculin (PPD)IBA
08/2012
1Plasminogen Activator Inhibitor 1IBA
08/2012
1Plasminogen InactivatorsIBA
08/2012
1Tissue Plasminogen Activator (Alteplase)FDA Link
07/2012
1Anti-Bacterial Agents (Antibiotics)IBA
02/2012
1Hemostatics (Antihemorrhagics)IBA
03/2010
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
03/2010
1Urokinase Plasminogen Activator ReceptorsIBA
03/2010
1Messenger RNA (mRNA)IBA
03/2010
1Macrophage Migration-Inhibitory FactorsIBA
02/2010
1AntibodiesIBA
02/2010
1Proteasome InhibitorsIBA
01/2009
1Bortezomib (Velcade)FDA Link
01/2009

Therapy/Procedure

1Length of Stay
01/2020
1Intravenous Administration
07/2013
1Drug Therapy (Chemotherapy)
01/2013
1Antibiotic Prophylaxis
02/2012